Brief: Cidara Therapeutics Restructures Workforce To Focus On Planned Clinical Development Of CD388
Sept 12 (Reuters) - Cidara Therapeutics Inc CDTX.O :
* CIDARA THERAPEUTICS RESTRUCTURES WORKFORCE TO FOCUS ON
PLANNED
CLINICAL DEVELOPMENT OF CD388
* CIDARA THERAPEUTICS INC: PLANNED REDUCTION IMPACTS
APPROXIMATELY
30% OF CIDARA WORKFORCE
* CIDARA THERAPEUTICS INC: CONTINUES BUSINESS DEVELOPMENT
DISCUSSIONS FOR ITS ONCOLOGY DFC PROGRAMS
* CIDARA THERAPEUTICS: REDUCTION IN WORKFORCE TO FOCUS ON
CLINICAL
DEVELOPMENT OF CD388
Source text for Eikon: ID:nGNX5ShNlV
Further company coverage: CDTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cidara Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Merck Seeks Up To $8 Billion In Us Bond Sale Tied To Cidara Deal - Bloomberg News
Merck rises after Wells Fargo upgrades stock to 'overweight'
Factbox: Major deals involving U.S. drugmakers and biotechs over the past decade